2009 annual financial data
Alnylam Pharmaceuticals 2009 Operating margin
Direct answer
Operating margin was -47.86%.
Operating income was -48,111,000 USD and net income was -47,590,000 USD.
Operating cash flow was -72,145,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 100,533,000 USD
- Operating income
- -48,111,000 USD
- Net income
- -47,590,000 USD
- Operating cash flow
- -72,145,000 USD